Sernova (TSX: SVA) (OTCQB: SEOVF) is a clinical-stage biotechnology company that is advancing a novel cell therapy platform for the treatment of chronic diseases. Our lead program is evaluating our Cell Pouch System™ as a potential ‘functional cure’ for insulin-dependent diabetes. In addition, we have a robust pipeline that includes preclinical programs in hemophilia A and hypothyroidism. Learn more on our website: https://www.sernova.com/.
View Top Employees from Sernova Corp.Website | http://www.sernova.com |
Ticker | SVA |
Revenue | $151 million |
Employees | 32 (27 on RocketReach) |
Founded | 2006 |
Address | 700 Collip Circle, Suite 114, London, Ontario N6G 4X8, CA |
Phone | (519) 858-5184 |
Fax | (519) 858-5099 |
Technologies |
JavaScript,
HTML,
Google Analytics
+12 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Developer Platform, Software, Therapeutics, Health Care |
Web Rank | 22 Million |
Keywords | Cell Pouch, Larynx Protection Bib Sernova |
Competitors | InGeneron, Juventas Therapeutics, Inc., Regeneus Ltd, RepliCel Life Sciences Inc., VIDEREGEN LIMITED |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541712 Companies, NAICS Code 5417 Companies |
Looking for a particular Sernova Corp. employee's phone or email?
The Sernova Corp. annual revenue was $151 million in 2024.
Philip Toleikis is the President and Chief Executive Officer of Sernova Corp..
27 people are employed at Sernova Corp..
Sernova Corp. is based in London, Ontario.
The NAICS codes for Sernova Corp. are [54171, 54, 541, 541712, 5417].
The SIC codes for Sernova Corp. are [873, 87].